Connect with us

National

Oxford coronavirus vaccine is safe and triggers strong immune response, human trials show – SBS News

The vaccine prompted no serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.

Published

on

post featured image

An experimental vaccine being developed by AstraZeneca and Oxford University against the coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
The vaccine, called AZD1222, has been described by the World Health Organisation’s chief scientist as the leading candidate in a global race to halt a pandemic that has killed more than 600,000 people.
More than 150 possible vaccines are in various stage…

Click here to view the original article.